Not exact matches
That paper reported that two - thirds of Type 2
diabetic men with chronic kidney disease have low testosterone levels and that
among patients on dialysis, a remarkable 90 percent have low testosterone.
Among type - 2
diabetic patients with an elevated risk of cardiovascular disease — those with high levels of triglycerides and low levels of «good» cholesterol (high - density lipoprotein or HDL)-- fenofibrate cut adverse cardiovascular outcomes by 30 per cent in women and 24 per cent in
men.
Diabetes doubled the risk of these geriatric conditions
among women, whereas no associations were found in
diabetic men.